尋常型白癜風(fēng)血清T細(xì)胞亞群、可溶性白介素-2受體、腫瘤壞死因子-α與中醫(yī)辨證的分析
[Abstract]:Purpose of the study: 1. To observe the levels of CD3, CD4, CD8, CD4/ CD8 and sIL-2R, TNF-and CD4/ CD8 and sIL-2R, TNF-and in peripheral blood of patients with vitiligo in normal control and observe the cellular immunity of vitiligo. 2. To analyze the correlation between TCM syndrome differentiation typing and peripheral blood T cell subpopulations and sIL-2R, TNF levels in patients with vitiligo. diagnosis and treatment of bed type Study object: From June 2011 to March 2012, the patients with vitiligo in the dermatological department of Chinese Hospital of Jiangsu Province, aged 18-65 years old A total of 35 patients were collected. The diagnosis and classification stage was based on the clinical classification of vitiligo and the standard of efficacy. (Revised 2010)>. None of these patients received corticosteroids, immunosuppressive agents and immunomodulators for nearly 3 months before Have a visit to it Method: 1. Test group: 35 cases (male 20 cases, female 15 cases) from 18 to 58 years old (33. 63) 10 Control group: 20 patients (10 males and 10 females) with age from 23 to 64 years old (35. 26 vs. 11. 12 years old) Kang individual, without any autoimmune disease history. 2. Adopt the unified design adult vitiligo clinical investigation questionnaire and ask the patient oneself, the content includes name, sex, age, course of course, Symptoms, signs, clinical classification, stage, tongue coating, tongue coating, etc. 3. Detection methods: CD3, CD4, CD8 were detected by flow cytometry. sIL-2R and TNF-1R were detected by enzyme-linked immunosorbent assay. 4. Statistical methods: Exc The statistical analysis of the database and SPSS19. O software was carried out by the el software. The independent sample t test, the rank sum test and the X2 test were adopted, and the difference between 0. 01P0. 05 was significant. Statistics The significance, P0. 01 were significant statistical significance for the difference. Results: 1. The age of patients with vitiligo in the normal progression period was 18-30 years, 30-There was no difference between 40 and 65 years of age, and there was no difference in gender composition (P0.05). There was no significant correlation between the different subtypes, age groups and sex (P <0.05). 3. Compared with the control group, the level of CD3 in peripheral blood of patients with vitiligo vulgaris was decreased significantly (P0.05), and the level of CD4 in peripheral blood was decreased, and there were very significant differences (P There was no significant difference in the levels of CD8 and CD4/ CD8 in patients with vitiligo (P <0.05). Compared with normal controls, the CD3 decreased in peripheral blood of patients with vitiligo, and there were significant differences (0. 01P0. 05); CD4 decreased, and there was very significant difference (P <0.05). There was no significant statistical difference between CD8 and CD4/ CD8 levels (P 0.05). CD3, CD4, CD in peripheral blood of patients with vitiligo Compared with the control group, the levels of sIL-2R in peripheral blood of patients with vitiligo vulgaris were significantly higher than those of normal control group (P <0.05). (P 0.01), the level of TNF-VEP in peripheral blood increased, and there were significant statistical differences (0. 01P0. 05). The levels of IL-2R and TNF-IL were significantly different from those of normal control group (P 0.01). Compared with the control group, there was no significant difference in serum sIL-2R and TNF level (P 0.05). CD8 There was no significant difference in the levels of CD4/ CD8, sIL-2R and TNF-tau (P <0.05). Conclusion: 1. The abnormal cellular immune function of patients with vitiligo vulgaris in this group is mainly characterized by peripheral blood CD3, CD4 water. Compared with the normal control group, the level of CD8 and C was significantly lower than that in the control group. Compared with the control group, the levels of sIL-2R and TNF levels in peripheral blood were significantly higher than those in the control group. Compared with the group, the peripheral blood C of patients with vitiligo in the stage of progressive vitiligo The levels of CD3 and CD4 decreased significantly, and the levels of sIL-2R and TNF-2R were significantly higher, but there was no statistical difference compared with the control group. The abnormal cellular immune function of vitiligo patients with ordinary progression suggested that the pathogenesis of vitiligo is related to autoimmune diseases, and it also supports the theory of autoimmune disease of vitiligo. The peripheral blood CD3, CD4, CD8, CD4/ CD8, sIL-2R and TNF in each TCM syndrome type of vitiligo.
【學(xué)位授予單位】:南京中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2012
【分類(lèi)號(hào)】:R758.41
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 解春桃;;白癜風(fēng)患者治療前后血清IL-2、SIL-2R、TNF-α和外周血B細(xì)胞及T淋巴細(xì)胞亞群檢測(cè)的臨床意義[J];放射免疫學(xué)雜志;2007年05期
2 汪京峽;段愛(ài)霞;張大軍;;白癜風(fēng)患者血清中白介素及腫瘤壞死因子水平變化的研究[J];皮膚病與性病;2006年01期
3 張學(xué)玲;毛東軍;劉影;葛邦友;沈景剛;沈奕;周彥;;白癜風(fēng)患者心理健康水平的評(píng)估及治療與細(xì)胞免疫功能的相關(guān)性研究[J];齊齊哈爾醫(yī)學(xué)院學(xué)報(bào);2010年14期
4 高天文,李強(qiáng),李春英,李志強(qiáng),王秋楓;白癜風(fēng)2008例臨床分析[J];中國(guó)皮膚性病學(xué)雜志;2002年05期
5 繆澤群,劉少金;尋常型白癜風(fēng)患者外周血兒茶酚胺類(lèi)物質(zhì)水平的研究[J];中國(guó)皮膚性病學(xué)雜志;2004年03期
6 李東寧;裴洪菊;周和清;葛明康;董淑鳳;張韻莉;孫健;楊素華;;白癜風(fēng)患者外周血T細(xì)胞亞群的檢測(cè)[J];中國(guó)皮膚性病學(xué)雜志;2006年07期
7 姜昱;雷立清;葉楠;周穎;張艷彩;;白癜風(fēng)患者外周血CD_4,CD_8檢測(cè)及免疫調(diào)節(jié)劑對(duì)其影響[J];中國(guó)皮膚性病學(xué)雜志;2009年05期
8 季素珍,施惠娟,沈麗玉;白癜風(fēng)患者血清中可溶性白介素2受體的檢測(cè)[J];中國(guó)皮膚性病學(xué)雜志;1999年01期
9 顧勁松,涂彩霞,譚雪晶,谷玲,林熙然;白癜風(fēng)患者血清白介素、腫瘤壞死因子α及粒細(xì)胞-巨噬細(xì)胞集落刺激因子檢測(cè)[J];中華皮膚科雜志;2003年02期
10 楊靜,盛晚香;細(xì)胞間黏附分子1和白介素8與白癜風(fēng)的相關(guān)性研究[J];中華皮膚科雜志;2003年11期
相關(guān)會(huì)議論文 前1條
1 盧良君;許愛(ài)娥;陳梅花;;白癜風(fēng)分型分期與中醫(yī)證型的關(guān)系[A];浙江省中西醫(yī)結(jié)合學(xué)會(huì)皮膚科專(zhuān)業(yè)委員會(huì)第九次學(xué)術(shù)年會(huì)暨省級(jí)繼教班資料匯編[C];2005年
,本文編號(hào):2275460
本文鏈接:http://sikaile.net/yixuelunwen/pifb/2275460.html